[1]
Amtul Mussawar Sami 2023. Intravitreal Bevacizumab (Avastin) for Primary Treatment of Diffuse Diabetic Macular Oedema.
Esculapio Journal of SIMS
. 5, 2 (Aug. 2023), 5–8.